文献速递淋巴瘤白血病

原子弹幸存者淋巴系肿瘤组织学亚型发病率的辐射剂量反应分析

Incidence of lymphoid neoplasms among atomic bomb survivors by histological subtype, 1950 to 1994.
PubMed 文献 · Blood · 2022-01-01

该研究将1950至1994年寿命研究队列中553例淋巴系肿瘤按WHO亚型分类,采用泊松回归评估辐射剂量与常见亚型的关系。结果显示辐射剂量与前体细胞肿瘤发生率强相关,每Gy超额相对危险度为16(95%CI 7.0至>533,年龄50岁),而成熟B细胞、T/NK细胞肿瘤及霍奇金淋巴瘤未见显著剂量反应。

要点

  • 辐射剂量与前体细胞肿瘤强相关,每Gy ERR为16(95%CI 7.0至>533,50岁)
  • 成熟B细胞、T/NK细胞肿瘤及霍奇金淋巴瘤未见显著辐射剂量反应
  • 非霍奇金淋巴瘤整体剂量反应仅见于男性,亚型分析显示主要由前体细胞肿瘤驱动

核心结论

  • 辐射剂量与淋巴系肿瘤整体的关联主要由前体细胞肿瘤的辐射效应驱动,成熟细胞肿瘤主要类别未见剂量反应证据。

研究设计与样本

  • 基于原子弹幸存者寿命研究队列的回顾性队列分析,纳入1950至1994年诊断的553例淋巴系肿瘤,按WHO亚型分类,采用泊松回归评估辐射剂量与常见亚型的关系。

主要发现

  • 成熟B细胞肿瘤占58%,成熟T细胞和NK细胞肿瘤占20%,前体细胞肿瘤占5%,霍奇金淋巴瘤占3%,其余15%为非霍奇金淋巴系肿瘤或未特指淋巴系肿瘤。
  • 非霍奇金淋巴瘤整体剂量反应显著见于男性而非女性。
  • 前体细胞肿瘤与辐射剂量强相关,50岁时每Gy超额相对危险度为16(95%CI 7.0至>533)。
  • 成熟B细胞、T/NK细胞肿瘤及弥漫大B细胞淋巴瘤、浆细胞骨髓瘤、成人T细胞白血病/淋巴瘤或霍奇金淋巴瘤均未见辐射剂量反应证据。

关键数值与推荐

  • 前体细胞肿瘤每Gy超额相对危险度为16(95%CI 7.0至>533),估计年龄为50岁。

临床怎么用

  • 辐射暴露后淋巴系肿瘤风险评估应关注前体细胞肿瘤亚型,成熟B/T/NK细胞肿瘤及霍奇金淋巴瘤的辐射归因风险证据有限。

局限性

  • 数据主要基于组织学诊断,部分病例分类为未特指淋巴系肿瘤。
  • 亚型分析仅针对较常见亚型,罕见亚型统计效能有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Epidemiological data have provided limited and inconsistent evidence on the relationship between radiation exposure and lymphoid neoplasms. We classified 553 lymphoid neoplasm cases diagnosed between 1950 and 1994 in the Life Span Study cohort of atomic bomb survivors into World Health Organization subtypes. Mature B-cell neoplasms represented 58%, mature T-cell and natural killer (NK)-cell neoplasms 20%, precursor cell neoplasms 5%, and Hodgkin lymphoma (HL) 3%, with the remaining 15% classified as non-Hodgkin lymphoid (NHL) neoplasms or lymphoid neoplasms not otherwise specified. We used Poisson regression methods to assess the relationship between radiation exposure and the more common subtypes. As in earlier reports, a significant dose response for NHL neoplasms as a group was seen for males but not females. However, subtype analyses showed that radiation dose was strongly associated with increased precursor cell neoplasms rates, with an estimated excess relative risk per Gy of 16 (95% Confidence interval: 7.0, >533) at age 50. The current data based primarily of tissue-based diagnoses suggest that the association between radiation dose and lymphoid neoplasms as a group is largely driven by the radiation effect on precursor cell neoplasms while presenting no evidence of a radiation dose response for major categories of mature cell neoplasms, either B- or T-/NK-cell, or more specific disease entities (diffuse large B-cell lymphoma, plasma cell myeloma, adult T-cell leukemia/lymphoma) or HL.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Fujihara M, Sakata R, Yoshida N, et al. Incidence of lymphoid neoplasms among atomic bomb survivors by histological subtype, 1950 to 1994. Blood. 2022. PMID: 34428282. doi:10.1182/blood.2020010475

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。